Devises / BDRX
BDRX: Biodexa Pharmaceuticals plc - American Depositary Shares
0.86
USD
0.02
(2.27%)
Le taux de change de BDRX a changé de -2.27% aujourd'hui. Au cours de la journée, l'instrument a été échangé à un minimum de 0.86 et à un maximum de 0.89.
Suivez la dynamique Biodexa Pharmaceuticals plc - American Depositary Shares. Les cotations en temps réel vous aideront à réagir rapidement aux changements du marché. En basculant entre différentes périodes, vous pouvez surveiller les tendances et la dynamique des taux de change par minutes, heures, jours, semaines et mois. Utilisez ces informations pour prévoir les changements du marché et prendre des décisions de trading éclairées.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
BDRX Nouvelles
- Investing Biodexa advances FAP treatment with phase 3 trial initiation
- Benzinga How Biodexa Is Racing To Get Its Phase 3 Program In FAP Under Way And Gain First-Mover Advantage In A $7B Addressable Market - Biodexa Pharmaceuticals (NASDAQ:BDRX), Palvella Therapeutics (NASDAQ:PVLA)
- TipRanks Upcoming Stock Splits This Week (July 28 to August 1) – Stay Invested - TipRanks.com
- Investing Biodexa Pharmaceuticals to implement 1:10 ADR ratio change
- Investing Biodexa files European clinical trial application for FAP treatment
- Investing Results of Annual General Meeting
- Investing Biodexa Announces Activation of First Clinical Study Site for Phase 3 Serenta Trial in Familial Adenomatous Polyposis (FAP)
- Investing Biodexa enrolls first patient in type 1 diabetes drug trial
- Benzinga Biodexa Hits Key Milestone For Its Type 1 Diabetes Candidate Tolimidone, Enrolls First Patient In Phase 2a Study - Biodexa Pharmaceuticals (NASDAQ:BDRX), Pfizer (NYSE:PFE)
- Investing Biodexa Pharmaceuticals changes share nominal value
- Investing Biodexa shareholders approve all resolutions at general meeting
- Investing Biodexa Announces Recruitment of First Patient in Phase 2 Study of Tolimidone in Type 1 Diabetes
- Investing Shareholder Update
- Benzinga Why Intuit Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket - 180 Life Sciences (NASDAQ:ATNF), Biodexa Pharmaceuticals (NASDAQ:BDRX)
- Investing Biodexa secures additional $3M for cancer drug trial
- Investing Biodexa Pharmaceuticals adjusts warrant exercise price
Range quotidien
0.86
0.89
Range Annuel
0.23
10.89
- Clôture Précédente
- 0.88
- Ouverture
- 0.88
- Bid
- 0.86
- Ask
- 1.16
- Plus Bas
- 0.86
- Plus Haut
- 0.89
- Volume
- 157
- Changement quotidien
- -2.27%
- Changement Mensuel
- 0.00%
- Changement à 6 Mois
- -80.09%
- Changement Annuel
- 21.13%
30 juillet, mercredi
12:15
USD
- Act
- 104 K
- Fcst
- 57 K
- Prev
- -33 K
12:30
USD
- Act
- 3.0%
- Fcst
- 0.4%
- Prev
- -0.5%
12:30
USD
- Act
- 2.0%
- Fcst
- 3.6%
- Prev
- 3.8%
12:30
USD
- Act
- 2.5%
- Fcst
- 3.3%
- Prev
- 3.5%
12:30
USD
- Act
- 2.1%
- Fcst
- 3.1%
- Prev
- 3.7%
12:30
USD
- Act
- 1.4%
- Fcst
- 0.8%
- Prev
- 0.5%
12:30
USD
- Act
- 6.3%
- Fcst
- -1.5%
- Prev
- -3.1%
14:00
USD
- Act
- -0.8%
- Fcst
- 1.6%
- Prev
- 1.8%
14:00
USD
- Act
- -2.8%
- Fcst
- 9.6%
- Prev
- 1.1%
14:00
USD
- Act
- 72.0
- Fcst
- Prev
- 72.6
14:30
USD
- Act
- Fcst
- 0.914 M
- Prev
- -3.169 M
14:30
USD
- Act
- Fcst
- 0.114 M
- Prev
- 0.455 M
14:30
USD
- Act
- Fcst
- 0.738 M
- Prev
- -0.740 M
14:30
USD
- Act
- Fcst
- -0.004 M
- Prev
- 0.095 M
14:30
USD
- Act
- Fcst
- -0.111 M
- Prev
- 2.931 M
14:30
USD
- Act
- Fcst
- 0.915 M
- Prev
- 0.282 M
14:30
USD
- Act
- Fcst
- 0.608 M
- Prev
- 0.003 M
14:30
USD
- Act
- Fcst
- 0.879 M
- Prev
- -1.738 M
14:30
USD
- Act
- Fcst
- Prev
- 0.087 M
14:30
USD
- Act
- Fcst
- Prev
- 1.6%
18:00
USD
- Act
- Fcst
- Prev
18:00
USD
- Act
- Fcst
- Prev
- 4.50%
18:30
USD
- Act
- Fcst
- Prev